Research Group GermanVasc, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Research Group GermanVasc, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; Department of Vascular and Endovascular Surgery, Asklepios Clinic Wandsbek, Asklepios Medical School, Hamburg, Germany; Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.
Eur J Vasc Endovasc Surg. 2023 Jul;66(1):85-93. doi: 10.1016/j.ejvs.2023.03.040. Epub 2023 Mar 25.
The goal of this study was to compare clinical outcomes in patients with peripheral arterial occlusive disease undergoing revascularisation by peripheral endovascular intervention (EVI), bypass surgery, endarterectomy (EA), and hybrid surgery in an unselected real world setting.
This was a German, prospective, multicentre, comparative cohort study, enrolling patients at hospital admission for revascularisation at 35 vascular centres with 12 months of follow up. Primary composite endpoints were major amputation or death, major adverse limb events, and any minor or major amputation. Twelve month incidences and hazard ratios (HRs) for the four subgroups and 95% confidence intervals (CIs) were estimated using Kaplan-Meier functions and Cox proportional hazard models. Sociodemographic and clinical characteristics, pharmacological treatment, and comorbidities were used to adjust for patient differentials (unique identifier ClinicalTrials.gov: NCT03098290).
In total, 4 475 patients were analysed (mean age 69 years, 69.4% males, and 31.5% suffering from chronic limb threatening ischaemia). After 12 months of follow up, 5.3% (95% CI 3.6 - 6.9%) of the patients experienced either death or major amputation, 7.2% (95% CI 4.8 - 9.6%) major adverse limb event, and 6.6% (95% CI 5.0 - 8.2%) any minor or major amputation. Compared with EVI, bypass surgery was associated with an increased risk of amputation or death (HR 2.59, 95% CI 1.75 - 3.85), major adverse limb event (HR 1.93, 95% CI 1.11 - 3.36), and any minor or major amputation (HR 2.12, 95% CI 1.42 - 3.16), and hybrid surgery with an increased risk of amputation or death (HR 2.29, 95% CI 1.27 - 4.13) and major adverse limb event (HR 1.62, 95% CI 1.03 - 2.54). After adjusting for patient differentials, no significant differences among study groups remained.
More favourable outcomes after EVI were completely attributed to differentials in patient characteristics and not procedure type. The current study emphasised that all competing approaches performed similarly in a real world setting.
本研究旨在比较外周血管腔内介入(EVI)、旁路手术、内膜切除术(EA)和杂交手术治疗外周动脉闭塞性疾病患者的临床结局,研究人群为未选择的真实世界环境中的患者。
这是一项德国前瞻性多中心比较队列研究,共纳入 35 个血管中心的 4475 名患者,在入院时接受血管重建治疗,并随访 12 个月。主要复合终点为主要截肢或死亡、主要肢体不良事件和任何次要或主要截肢。使用 Kaplan-Meier 函数和 Cox 比例风险模型估计四个亚组的 12 个月发生率和风险比(HRs)及其 95%置信区间(CI)。使用人口统计学和临床特征、药物治疗和合并症来调整患者差异(独特标识符 ClinicalTrials.gov:NCT03098290)。
共分析了 4475 例患者(平均年龄 69 岁,69.4%为男性,31.5%患有慢性肢体威胁性缺血)。在 12 个月的随访中,5.3%(95%CI3.6-6.9%)的患者发生死亡或主要截肢,7.2%(95%CI4.8-9.6%)发生主要肢体不良事件,6.6%(95%CI5.0-8.2%)发生任何次要或主要截肢。与 EVI 相比,旁路手术与截肢或死亡风险增加相关(HR2.59,95%CI1.75-3.85)、主要肢体不良事件(HR1.93,95%CI1.11-3.36)和任何次要或主要截肢(HR2.12,95%CI1.42-3.16)相关,而杂交手术与截肢或死亡风险增加相关(HR2.29,95%CI1.27-4.13)和主要肢体不良事件(HR1.62,95%CI1.03-2.54)。在调整了患者差异后,研究组之间没有显著差异。
EVI 后更有利的结果完全归因于患者特征的差异,而不是手术类型。本研究强调,在真实世界环境中,所有竞争方法的表现都相似。